Top compounds associated with response to NRF1


Feature Type Standardized
Nominal ANOVA
mRNA AT-7519 GDSC1000 pan-cancer AAC 0.17 1e-07
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.2 2e-07
mRNA PD318088 CTRPv2 pan-cancer AAC -0.2 3e-07
mRNA CD-437 CTRPv2 pan-cancer AAC 0.18 3e-07
mRNA GW843682X CTRPv2 pan-cancer AAC 0.19 4e-07
mRNA (5Z)-7-Oxozeaenol GDSC1000 pan-cancer AAC -0.17 5e-07
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 5e-07
mRNA RDEA119 GDSC1000 pan-cancer AAC -0.17 5e-07
mRNA XMD13-2 GDSC1000 pan-cancer AAC 0.17 6e-07
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.19 7e-07
Download CSV